Dodge & Cox’s BioNTech BNTX Stock Holding History

Dodge & Cox’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342M	Buy	3,677,591 +800	+0%	+$75.3K	0.18%	91
2026 Q1	$327M	Buy	3,676,791 +62,300	+2%	+$6.4M	0.18%	94
2025 Q4	$344M	Sell	3,614,491 -32,600	-0.9%	-$3.28M	0.19%	91
2025 Q3	$360M	Buy	3,647,091 +2,769,654	+316%	+$296M	0.19%	91
2025 Q2	$93.4M	Buy	+877,437	New	+$88.6M	0.05%	103

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dodge & Cox's BNTX Position: Q2 2026 in Review

Dodge & Cox increased its BioNTech (BNTX) stake by 0.02% in Q2 2026, buying an estimated $75.3K and bringing the position to 3,677,591 shares worth $342M. The position accounts for 0.18% of the portfolio, ranked #91.

Dodge & Cox first reported a position in BNTX in Q2 2025 and has held it in 5 quarters since. The position peaked at $360M in Q3 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Dodge & Cox held 3,677,591 shares of BioNTech worth $342M as of Q2 2026.
Dodge & Cox bought 800 BioNTech shares in Q2 2026, an estimated $75.3K.
BioNTech made up 0.18% of Dodge & Cox's portfolio in Q2 2026, its #91 holding.
Dodge & Cox first reported a position in BioNTech in Q2 2025 and has held it in 5 quarters since.
Dodge & Cox's BioNTech position peaked at $360M in Q3 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.